Trospium Chloride XR in Obese Female Patients With Overactive Bladder
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-07-02
- Last Posted Date
- 2013-01-21
- Lead Sponsor
- Allergan
- Target Recruit Count
- 127
- Registration Number
- NCT00932022
Long Term Follow-up Study of Safety and Efficacy of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-08
- Last Posted Date
- 2019-04-30
- Lead Sponsor
- Allergan
- Target Recruit Count
- 829
- Registration Number
- NCT00915525
Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Allergan
- Target Recruit Count
- 557
- Registration Number
- NCT00910845
Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2013-03-05
- Lead Sponsor
- Allergan
- Target Recruit Count
- 548
- Registration Number
- NCT00910520
Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-22
- Last Posted Date
- 2012-09-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 368
- Registration Number
- NCT00907426
A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-07
- Last Posted Date
- 2013-09-30
- Lead Sponsor
- Allergan
- Target Recruit Count
- 61
- Registration Number
- NCT00894517
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-21
- Last Posted Date
- 2012-11-04
- Lead Sponsor
- Allergan
- Target Recruit Count
- 176
- Registration Number
- NCT00884585
A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-06
- Last Posted Date
- 2019-05-01
- Lead Sponsor
- Allergan
- Target Recruit Count
- 397
- Registration Number
- NCT00876447
A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-04-03
- Last Posted Date
- 2011-12-19
- Lead Sponsor
- Allergan
- Target Recruit Count
- 66
- Registration Number
- NCT00874887
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-03-18
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- Allergan
- Target Recruit Count
- 12
- Registration Number
- NCT00863551
© Copyright 2024. All Rights Reserved by MedPath